Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, JMI Hospital Requisite Manufacturing's average EBITDA Per Share Growth Rate was -26.90% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -8.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of JMI Hospital Requisite Manufacturing was -3.00% per year. The lowest was -8.60% per year. And the median was -5.80% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
JMI Hospital Requisite Manufacturing 5-Year EBITDA Growth Rate Related Terms
DHA:JHRML vs ISRG, BDX, RMD: 5-Year EBITDA Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMI Hospital Requisite Manufacturing 5-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate falls into.
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 0.00% mean?
JMI Hospital Requisite Manufacturing (DHA:JHRML) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for JMI Hospital Requisite Manufacturing and its competitors.
Is JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate too high?
JMI Hospital Requisite Manufacturing's current 5-Year EBITDA Growth Rate is 0.00%. Overall, JMI Hospital Requisite Manufacturing has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate compare to ISRG and BDX?
JMI Hospital Requisite Manufacturing's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
A good 5-Year EBITDA Growth Rate depends on the Medical Devices & Instruments industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for JMI Hospital Requisite Manufacturing and its competitors. JMI Hospital Requisite Manufacturing's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Hospital Requisite Manufacturing stock overvalued right now?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing (DHA:JHRML) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT49.93, compared to a current price of BDT43.10 — trading 13.7% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. JMI Hospital Requisite Manufacturing's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For JMI Hospital Requisite Manufacturing (DHA:JHRML), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMI Hospital Requisite Manufacturing (DHA:JHRML) Overvalued in 2026?
Based on GuruFocus' analysis, JMI Hospital Requisite Manufacturing stock appears to be undervalued.
The current stock price of BDT43.10 is trading 13.7% below its estimated GF Value™ of BDT49.93.
GuruFocus considers JMI Hospital Requisite Manufacturing to be Modestly Undervalued.
Key valuation signals for DHA:JHRML:
5-Year EBITDA Growth Rate: 0.00%
GF Value™: BDT49.93 vs. price of BDT43.10 (13.7% below fair value)
No single metric tells the full story. See the DHA:JHRML stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMI Hospital Requisite Manufacturing Ltd is a Bangladeshi manufacturer of disposable medical devices and hospital consumables. Its product range includes surgical sutures and gloves, IV cannulas, infusion and blood transfusion sets, scalp vein sets, bulk needles, disposable scalpels, nasal oxygen cannulas, urine drainage bags, and blister film used as packaging material. The company serves hospitals, clinics, healthcare distributors, and government health agencies, primarily within Bangladesh, and also exports to several international markets. It manufactures at facilities in Bangladesh and sells under its own brand as well as on a contract basis for other medical device companies. Revenue is generated through the sale of finished medical devices and components to healthcare providers and distributors, with growth tied to domestic healthcare spending and export demand for low-cost disposable medical supplies.
68GF Score
Get the complete analysis for DHA:JHRML
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:JHRML has been successfully added to your 
